Comparison of the PowerChek SARS-CoV-2, Influenza A&B, RSV Multiplex Real-time PCR Kit and BioFire Respiratory Panel 2.1 for simultaneous detection of SARS-CoV-2, influenza A and B, and respiratory syncytial virus
暂无分享,去创建一个
Sun Ae Yun | N. Lee | Ja-Hyun Jang | H. Huh | Ji-Youn Kim | Jong-Won Kim | Tae Yeul Kim | Hyang Jin Shim
[1] K. Carroll,et al. Clinical performance of the GenMark Dx ePlex respiratory pathogen panels for upper and lower respiratory tract infections. , 2021, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[2] R. Lai,et al. Evaluation of the Xpert Xpress SARS-CoV-2/Flu/RSV Assay for Simultaneous Detection of SARS-CoV-2, Influenza A and B Viruses, and Respiratory Syncytial Virus in Nasopharyngeal Specimens , 2021, Journal of Clinical Microbiology.
[3] Ji-Rong Yang,et al. Novel dual multiplex real-time RT-PCR assays for the rapid detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus using the BD MAX open system , 2021, Emerging microbes & infections.
[4] K. Carroll,et al. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV Test , 2020, Journal of Clinical Microbiology.
[5] M. Caza,et al. Evaluation of the BioFire® COVID-19 test and Respiratory Panel 2.1 for rapid identification of SARS-CoV-2 in nasopharyngeal swab samples , 2020, Diagnostic Microbiology and Infectious Disease.
[6] V. Calvez,et al. Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19 , 2020, International Journal of Infectious Diseases.
[7] J. Ridgway,et al. Characterizing coinfection in children with COVID-19: A dual center retrospective analysis , 2020, Infection Control & Hospital Epidemiology.
[8] S. Kanjilal,et al. Influenza in the COVID-19 Era. , 2020, JAMA.
[9] Jia Wei,et al. Coinfection of SARS-CoV-2 and Other Respiratory Pathogens , 2020, Infection and drug resistance.
[10] M. J. Broadhurst,et al. Clinical evaluation of the BioFire® Respiratory Panel 2.1 and detection of SARS-CoV-2 , 2020, Journal of Clinical Virology.
[11] Q. Lepiller,et al. Clinical features of COVID-19 and influenza: a comparative study on Nord Franche-Comte cluster , 2020, Microbes and Infection.
[12] Á. Soriano,et al. SARS-CoV-2 and influenza virus co-infection , 2020, The Lancet.
[13] Gilles Collin,et al. Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the First Rapid Multiplex PCR Commercial Assay for SARS-CoV-2 Detection , 2020, Journal of Clinical Microbiology.
[14] N. Shah,et al. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens. , 2020, JAMA.
[15] Q. Ding,et al. The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China , 2020, Journal of medical virology.
[16] Yongjun Li,et al. Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China , 2020, Emerging infectious diseases.
[17] Huadong Zhu,et al. Characteristics of respiratory virus infection during the outbreak of 2019 novel coronavirus in Beijing , 2020, International Journal of Infectious Diseases.